NeuPath Health Inc.
NPTH.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.47M | 15.89M | 16.03M | 17.08M | 13.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.47M | 15.89M | 16.03M | 17.08M | 13.47M |
| Cost of Revenue | 12.62M | 12.97M | 12.97M | 13.70M | 10.94M |
| Gross Profit | 2.84M | 2.91M | 3.06M | 3.38M | 2.54M |
| SG&A Expenses | 1.83M | 2.51M | 2.30M | 2.18M | 1.80M |
| Depreciation & Amortization | 390.50K | 403.80K | 404.40K | 414.90K | 416.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.85M | 15.88M | 15.68M | 16.29M | 13.16M |
| Operating Income | 619.90K | 5.00K | 355.00K | 784.20K | 317.00K |
| Income Before Tax | 336.50K | -271.10K | 18.20K | 354.20K | -135.20K |
| Income Tax Expenses | 64.00K | -31.60K | 86.40K | 107.00K | 92.70K |
| Earnings from Continuing Operations | 272.50K | -239.60K | -68.20K | 247.20K | -227.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -47.50K | -53.80K | -42.80K | -60.70K | -59.90K |
| Net Income | 225.10K | -293.40K | -111.10K | 186.50K | -287.80K |
| EBIT | 619.90K | 5.00K | 355.00K | 784.20K | 317.00K |
| EBITDA | 1.01M | 594.30K | 759.40K | 1.20M | 733.00K |
| EPS Basic | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Average Basic Shares Outstanding | 56.29M | 56.21M | 56.45M | 56.57M | 56.22M |
| Average Diluted Shares Outstanding | 59.29M | 56.21M | 58.26M | 58.15M | 57.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |